Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Search results

Found 30896 matches for

European Centre of Excellence at NDORMS

NDORMS has been designated a EULAR Centre of Excellence 2020-2025, in recognition of our continued high-quality research publications in rheumatology.

Size does matter

Researchers from the Universities of Oxford, Nottingham and Zhejiang have found that the precise measurement of joint lining inflammation corresponds well with osteoarthritic knee pain. It's even better when size of the joint is taken into consideration and this should be considered when examining treatment effects in clinical trials.

An unexpected repair function for neutrophils

In a collaboration with scientists at the Centro Nacional de Investigaciones Cardiovasculares (CNIC), Kennedy researchers have contributed to the discovery that neutrophils have many more functions in the body than previously thought. This finding suggests that neutrophil tissue-specific plasticity could be exploited in designing new treatments for neutrophil driven diseases, including cancer.

HUSH trial opens to recruitment!

The HUSH trial has received OCTRU Green Light approval and is now open to recruitment!

Ethnic representation within the Tendon Human Cell Atlas to be improved with Chan Zuckerberg Initiative funding

NDORMS researchers have been awarded funding from the Chan Zuckerberg Initiative to ensure that tendon samples from understudied ethnic groups are included in the Tendon Human Cell Atlas.

Knee OA guidance for clinicians simplified and streamlined

Researchers review the similarities and differences between OARSI and ESCEO 2019 guidelines for the management of knee OA and provide a narrative to help steer health-care providers through the complexities of non-surgical management of the disease.

Understanding the physics of the immune response necessitates new technology

Professor Marco Fritzsche has joined the Kennedy Institute as the Principal Investigator of the Biophysical Immunology Laboratory (BPI), as part of a joint appointment with the Rosalind Franklin Institute. His lab is leading the development of a lattice light sheet microscope that will significantly advance the study of live cells.

CD2 corolla calls T cells to arms

A team from the University of Oxford has visualised how key cells of the immune system lock onto cancerous or infected cells to destroy them. The work was led by the Mike Dustin’s group at the Kennedy Institute of Rheumatology and experts in colorectal and ovarian cancers from across Oxford and computational biologists at the University of Birmingham.

Likely culprits causing blood vessel lesions in vasculitis identified

NDORMS researchers identify a subset of immune cells that could be a new therapeutic target to treat inflamed blood vessels in Giant Cell Arteritis (GCA) and other forms of inflammatory vascular disease.

Review of proposed FDA regulation reveals the extent of financial ties to industry

A review of public comments on a proposed FDA regulatory framework, for modifications to artificial intelligence and machine learning-based software as a medical device, has found that 63% came from parties with financial ties to industry, and that the majority, 86% did not cite any scientific evidence.

Professor Stride announced as Honorary Fellow of IET

Institution of Engineering and Technology announces 16 Honorary Fellows to mark its 150th year. Professor Stride was awarded the Fellowship in recognition of her contribution to biomedical engineering and research into treatment of major diseases.

Carpal tunnel decompression surgery found to be a safe option for patients

One of the leading causes of workplace absence, carpal tunnel syndrome, can be treated successfully with decompression surgery without serious complications according to research from NDORMS.

Hospitalised COVID-19 patients shown to be younger and healthier than flu patients

Patients hospitalised with COVID-19 were more likely male, younger and, in both the US and Spain, had fewer comorbidities and lower medication use than hospitalized influenza patients according to a recent study published recently by the Observational Health Data Sciences and Informatics (OHDSI) community.

Research review reveals potential to improve colon cancer treatments

Researchers at the Kennedy Institute review the growing body of literature on the role of the microbiome in colorectal cancer

Oxford researchers start new trial on the use of anti-TNF to treat Covid-19 in care homes

Researchers at the University of Oxford are starting a new study to explore the effectiveness of the anti-tumour necrosis factor (anti-TNF) drug adalimumab as a treatment for patients with COVID-19 in the community, especially care homes. The AVID-CC trial, which will be conducted by Oxford Clinical Trials Research Unit (OCTRU), will enrol up to 750 patients from community care settings throughout the UK.

Professor Chris Lavy awarded prestigious honorary fellowship by British Orthopaedic Association

Professor of Orthopaedic and Tropical Surgery and Consultant Orthopaedic and Spine Surgeon Chris Lavy has been awarded a prestigious honorary fellowship by the British Orthopaedic Association (BOA).

Key discovery in Psoriatic Arthritis points way for developing targeted treatments

A new study has revealed psoriatic arthritis may be activated by the same trigger in different patients. Researchers from the University of Oxford and the Wellcome Sanger Institute identified high levels of a specific receptor in immune cells from psoriatic arthritis patients, giving the strongest evidence yet of a single cause for the disease.

Operation Ouch!

CBBC's Operation Ouch have been helping to raise awareness of participation in clinical trials for children.

NEON trial opens to recruitment!

The NEON trial has received OCTRU Green Light approval and is about to open sites to recruitment!

Research success leads to expansion

A new wing is being built to expand the Botnar Research Centre and advance its research into musculoskeletal science and bioengineering technologies.

Load More